NNC0560-0004

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0560-0004, covering 2025-08-20 to 2025-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults. [Phase 1]

See pricing